title: Estimating the effectiveness of simian immunodeficiency virus-specific CD8+ T cells from the dynamics of viral immune escape.
abstract: Antiviral CD8(+) T cells are thought to play a significant role in limiting the viremia of human and simian immunodeficiency virus (HIV and SIV, respectively) infections. However, it has not been possible to measure the in vivo effectiveness of cytotoxic T cells (CTLs), and hence their contribution to the death rate of CD4(+) T cells is unknown. Here, we estimated the ability of a prototypic antigen-specific CTL response against a well-characterized epitope to recognize and kill infected target cells by monitoring the immunodominant Mamu-A*01-restricted Tat SL8 epitope for escape from Tat-specific CTLs in SIVmac239-infected macaques. Fitting a mathematical model that incorporates the temporal kinetics of specific CTLs to the frequency of Tat SL8 escape mutants during acute SIV infection allowed us to estimate the in vivo killing rate constant per Tat SL8-specific CTL. Using this unique data set, we show that at least during acute SIV infection, certain antiviral CD8(+) T cells can have a significant impact on shortening the longevity of infected CD4(+) T cells and hence on suppressing virus replication. Unfortunately, due to viral escape from immune pressure and a dependency of the effectiveness of antiviral CD8(+) T-cell responses on the availability of sufficient CD4(+) T cells, the impressive early potency of the CTL response may wane in the transition to the chronic stage of the infection.
authors: Graduate Program in population Biology, Ecology, and Evolution, Emory University, 954 Gatewood Road, Atlanta, GA 30329, USA.
authors: Judith N
authors: JN
authors: Mandl
authors: Roland R
authors: RR
authors: Regoes
authors: David A
authors: DA
authors: Garber
authors: Mark B
authors: MB
authors: Feinberg
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000378:metabolism*; D000939:Epitopes / Q000737:chemistry; D007107:Immune System / Q000821:virology*; D008253:Macaca mulatta; D008954:Models, Biological; D015233:Models, Statistical; D008962:Models, Theoretical; D008969:Molecular Sequence Data; D009154:Mutation; D015302:Simian Immunodeficiency Virus / Q000235:genetics*; D013997:Time Factors; D014773:Virology / Q000379:methods*
chemical_list: D000939:Epitopes
references: Nature. 1995 Jan 12;373(6510):117-22
references: 7529365
references: J Immunol. 2007 Sep 1;179(5):3026-34
references: 17709517
references: J Virol. 1995 Aug;69(8):5087-94
references: 7541846
references: J Virol. 1996 Nov;70(11):7894-9
references: 8892912
references: Nat Med. 1997 Feb;3(2):205-11
references: 9018240
references: Curr Biol. 1997 Mar 1;7(3):R136-40
references: 9162473
references: AIDS. 1998;12 Suppl A:S35-42
references: 9632982
references: J Immunol. 1998 Jun 15;160(12):6062-71
references: 9637523
references: J Exp Med. 1999 Mar 15;189(6):991-8
references: 10075982
references: J Immunol. 1999 May 1;162(9):5127-33
references: 10227983
references: J Virol. 2005 May;79(9):5721-31
references: 15827187
references: Nature. 2005 Apr 28;434(7037):1093-7
references: 15793563
references: Nature. 2005 Apr 28;434(7037):1148-52
references: 15793562
references: J Virol. 2005 Nov;79(21):13579-86
references: 16227278
references: J Virol. 2005 Dec;79(23):14986-91
references: 16282500
references: Nat Med. 2006 Mar;12(3):289-95
references: 16520776
references: Virology. 2006 Mar 30;347(1):140-6
references: 16387340
references: PLoS Biol. 2006 Apr;4(4):e90
references: 16515366
references: PLoS Comput Biol. 2006 Mar;2(3):e24
references: 16604188
references: J Virol. 2006 Oct;80(19):9861-4
references: 16973590
references: Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1599-603
references: 17242364
references: J Virol. 2007 Mar;81(6):2624-34
references: 17192314
references: Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6365-70
references: 17404226
references: Immunol Cell Biol. 2007 Jun;85(4):274-9
references: 17420769
references: Nature. 2000 Sep 21;407(6802):386-90
references: 11014195
references: Nature. 2001 Apr 19;410(6831):980-7
references: 11309628
references: J Virol. 2001 Dec;75(24):11983-91
references: 11711588
references: Proc Biol Sci. 2002 Sep 22;269(1503):1887-93
references: 12350250
references: Nat Immunol. 2002 Nov;3(11):1061-8
references: 12368910
references: J Virol. 2002 Dec;76(23):12173-84
references: 12414957
references: J Virol. 2003 Feb;77(3):2081-92
references: 12525643
references: J Virol. 2003 Apr;77(8):4911-27
references: 12663797
references: J Virol. 2003 Apr;77(8):5037-8
references: 12663814
references: J Immunol. 2003 Oct 1;171(7):3837-46
references: 14500685
references: J Virol. 2003 Dec;77(23):12572-8
references: 14610180
references: J Virol. 2004 Mar;78(5):2581-5
references: 14963161
references: Nat Med. 2004 Mar;10(3):282-9
references: 14770175
references: Nat Med. 2004 Mar;10(3):275-81
references: 14966520
references: J Virol. 2004 Apr;78(7):3233-43
references: 15016844
references: J Clin Invest. 2004 Mar;113(6):836-45
references: 15067316
references: J Virol. 2004 May;78(9):4866-75
references: 15078967
references: Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5640-5
references: 15064398
references: Lancet Infect Dis. 2004 Jul;4(7):397-413
references: 15219551
references: Nat Rev Immunol. 2004 Aug;4(8):630-40
references: 15286729
references: J Virol. 1989 Sep;63(9):3708-13
references: 2760980
references: AIDS. 1990 Nov;4(11):1095-103
references: 2282182
references: Proc Natl Acad Sci U S A. 1991 May 1;88(9):4045-9
references: 2023953
references: AIDS Res Hum Retroviruses. 1994 Feb;10(2):213-20
references: 8198874
references: Nucleic Acids Res. 1994 Nov 11;22(22):4673-80
references: 7984417
references: Nature. 1995 Jan 12;373(6510):123-6
references: 7816094